Nanoflex Robotics System for Vascular Interventions Introduced in North America at Jacobs Institute

March 7, 2024—Nanoflex Robotics AG, which is headquartered in Switzerland, announced the introduction in North America of its remote-ready robotics system for vascular interventions.

The company recently installed the first system for neurovascular procedures at The Jacobs Institute, a nonprofit medical device innovation center in Buffalo, New York. The system will enable usability testing, in-vivo studies, and training. It will also serve as a site for physician demonstrations.

The Jacobs Institute’s testing facility is located within the University at Buffalo’s Canon Stroke and Vascular Research Center. Adnan Siddiqui, MD, is CEO and Chief Medical Officer of the Jacobs Institute and Vice Chairman and Professor of Neurosurgery in the University at Buffalo’s Jacobs School of Medicine and Biomedical Sciences.

“Robotic neurovascular intervention is undoubtedly the future,” commented Dr. Siddiqui in the company’s press release. “We are delighted to work with Nanoflex Robotics to prove this concept.”

According to the company, the Nanoflex Robotics system uses a compact magnetic field generator and a navigation control unit to guide ultra-flexible devices through the body for a range of complex vascular interventions. The technology allows physicians to directly control, bend, and guide the tip of the guidewire through the body’s vasculature, to conduct procedures at the bedside or thousands of miles away.

“We are thrilled to collaborate with the esteemed Jacobs Institute in New York for the first installation of our robotics system,” stated Matt Curran, CEO of Nanoflex Robotics, in the press release. “We believe remote robotics has the potential to transform surgical outcomes and benefit patients, by enabling greater and earlier access to critical treatments.”

The company further advised that it recently received ISO 13485 certification for its quality management system in designing and manufacturing remote robotic devices for endovascular interventions.